» Articles » PMID: 12660271

A Prospective Study of Predictive Factors of Ovarian Response in 'standard' IVF/ICSI Patients Treated with Recombinant FSH. A Suggestion for a Recombinant FSH Dosage Normogram

Overview
Journal Hum Reprod
Date 2003 Mar 28
PMID 12660271
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim was to identify independent predictors of ovarian response to recombinant (r)FSH through a multiple regression analysis.

Methods: Prospective study including 145 'standard' patients treated with 150 IU/day of rFSH during their first IVF/ICSI cycle. Down-regulation was achieved with long agonist protocol. The following were examined as possible predictive factors: age, body mass index, cycle length, smoking status and on day 2-5: total ovarian volume, total number of antral follicles (<10 mm), total Doppler score of the ovarian stromal blood flow, serum FSH, LH, estradiol, inhibin B, and testosterone.

Results: Total number of antral follicles, total Doppler score, serum FSH, LH, estradiol, inhibin B, smoking status and cycle length were independent predictors of the number of aspirated follicles. The number of oocytes was predicted by the total number of antral follicles, total Doppler score, serum testosterone and smoking status. In bivariate linear regression analyses ovarian volume was a highly significant predictor of both the number of follicles (P < 0.001) and the number of oocytes (P < 0.001).

Conclusions: Among 12 investigated possible predictive factors in 'standard' patients, the total number of antral follicles and ovarian stromal blood flow assessed by total Power Doppler score are the two most significant predictors of ovarian response. Suggestion for an rFSH dosage normogram is presented.

Citing Articles

Cost-Effectiveness and Clinical Outcomes of Controlled Ovarian Stimulation With Follitropin Delta and Follitropin Alfa: A Retrospective Study.

Kobanawa M, Iwami N, Hanaoka M, Enatsu K, Ichiyama T Cureus. 2025; 16(12):e76371.

PMID: 39867102 PMC: 11759662. DOI: 10.7759/cureus.76371.


Development and validation of a gonadotropin dose selection model for optimized ovarian stimulation in IVF/ICSI: an individual participant data meta-analysis.

Schouten N, Wang R, Torrance H, Van Tilborg T, Bastu E, Bergh C Hum Reprod Update. 2024; 31(2):116-132.

PMID: 39707165 PMC: 11879166. DOI: 10.1093/humupd/dmae032.


Analytical Investigation of the Profile of Human Chorionic Gonadotropin in Highly Purified Human Menopausal Gonadotrophin Preparations.

Capolupo A, Petrocchi S, Melchiorre M, Jonas K, DHooghe T, Hanyaloglu A Int J Mol Sci. 2024; 25(17).

PMID: 39273352 PMC: 11395176. DOI: 10.3390/ijms25179405.


Verification of the utility of the gonadotropin starting dose calculator in progestin-primed ovarian stimulation: A comparison of empirical and calculated controlled ovarian stimulation.

Kobanawa M, Yoshida J Reprod Med Biol. 2024; 23(1):e12586.

PMID: 38827517 PMC: 11140174. DOI: 10.1002/rmb2.12586.


Can AMH levels predict the need to step up FSH dose for controlled ovarian stimulation following a long GnRH agonist protocol in PCOS women?.

Huang H, Gao H, Shi Y, Deng B, He X, Lin J Reprod Biol Endocrinol. 2023; 21(1):121.

PMID: 38110998 PMC: 10726541. DOI: 10.1186/s12958-023-01173-8.